Evolution of peptidoglycan biosynthesis under the selective pressure of antibiotics in Gram-positive bacteria.
Acquisition of resistance to the two classes of antibiotics therapeutically used against Gram-positive bacteria, the glycopeptides and the beta-lactams, has revealed an unexpected flexibility in the peptidoglycan assembly pathway. Glycopeptides select for diversification of the fifth position of stem pentapeptides because replacement of D-Ala by D-lactate or D-Ser at this position prevents binding of the drugs to peptidoglycan precursors. The substitution is generally well tolerated by the classical D,D-transpeptidases belonging to the penicillin-binding protein family, except by low-affinity enzymes. Total elimination of the fifth residue by a D,D-carboxypeptidase requires a novel cross-linking enzyme able to process the resulting tetrapeptide stems. This enzyme, an L,D-transpeptidase, confers cross-resistance to beta-lactams and glycopeptides. Diversification of the side chain of the precursors, presumably in response to the selective pressure of peptidoglycan endopeptidases, is controlled by aminoacyl transferases of the Fem family that redirect specific aminoacyl-tRNAs from translation to peptidoglycan synthesis. Diversification of the side chains has been accompanied by a parallel divergent evolution of the substrate specificity of the L,D-transpeptidases, in contrast to the D,D-transpeptidases, which display an unexpected broad specificity. This review focuses on the role of antibiotics in selecting or counter-selecting diversification of the structure of peptidoglycan precursors and their mode of polymerization.
Mainardi
Jean-Luc
JL
INSERM, U872, LRMA, Centre de Recherche des Cordeliers, Paris, France.
Villet
Régis
R
Bugg
Timothy D
TD
Mayer
Claudine
C
Arthur
Michel
M
D019943:Amino Acid Substitution; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D019729:Carbon-Oxygen Ligases / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D024881:Drug Resistance, Bacterial; D019143:Evolution, Molecular; D006094:Gram-Positive Bacteria / Q000187:drug effects* / Q000378:metabolism; D005810:Multigene Family / Q000187:drug effects; D009154:Mutation; D046915:Penicillin-Binding Proteins / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism; D010457:Peptidoglycan / Q000096:biosynthesis*; D013379:Substrate Specificity
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D046915:Penicillin-Binding Proteins; D010457:Peptidoglycan; C071437:VanA ligase, Bacteria; D019729:Carbon-Oxygen Ligases